Genenta Science (GNTA)

• Market cap: $53.9M
• 1 day: 0.44%
• 5 days: -11.88%
• 1 month: -27.22%
• 3 months: -39.47%
• 6 months: -43.63%
• Year to date: -49.23%
• 1 year: -52.67%
• 5 years: -79.09%
• 10 years: -79.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13